Matchups
Head‑to‑head, with a verdict
Every comparison here ends with an answer rather than a shrug. Trial data, availability, and cost — then a call on which fits which person.
Retatrutide vs Ozempic: Two Very Different Things
These are not alternatives. Ozempic is approved for type 2 diabetes and prescribable today; retatrutide is investigational, with no legal supply route.
Read the verdict →
Retatrutide vs Semaglutide: Should You Wait?
Do not wait. Semaglutide works now; retatrutide is a 2027 question at the earliest, and untreated obesity does not pause while a pipeline matures.
Read the verdict →
Retatrutide vs Tirzepatide: What the Trial Data Actually Shows
Tirzepatide is the answer for anyone treating obesity today. Retatrutide has better trial numbers and no approval, no prescription route, and no legal supply.
Read the verdict →